We're hiring! Come join our commercial team as a Client Success Manager and help us fulfill our mission to to maximize the efficiency and effectiveness of providers by transforming how medications are prescribed and managed.
About us
Genomind is a leading precision health company focused on optimizing the treatment experience for individuals and healthcare providers through actionable genetic insights and innovative health technology. Since its founding, Genomind has expanded beyond its flagship of pharmacogenetic testing to develop a comprehensive portfolio of precision health services for individual and population-level patient care. Built on the foundation of compassionate care and clinical expertise, Genomind is empowering a more targeted and personalized approach to medication management, and a new standard of care. Genomind's Pharmacogenetic Test is an industry-leading prescription genetic test that equips healthcare professionals with tools they need to more quickly identify a personalized treatment plan for their patients. Genomind offers more comprehensive genetic guidance, superior speed and accuracy, state-of-the-art digital tools, and scheduled PhD and PharmD expert consultations. This test is available via clinician order only. Genomind® Mental Health Map™ is the first-ever genetic test available direct-to-consumer designed specifically for mental health and wellness. It provides powerful new insights and actions through reports in the 7 Core Genetic Mental Health Capabilities™ by analyzing genetic makeup across 35 genes, 38 genetic variants, 21 genetic mechanisms, and 59 mental health predispositions. Included is a free consult to help individuals better take advantage of their results. This test does not inform on medications nor require clinician order. If you are a patient who is interested in our testing, or a clinician interested in using these tools in your practice, please contact us at 877-895-8658 or customerservice@genomind.com. Learn more at www.genomind.com.
- Website
-
http://www.genomind.com
External link for Genomind
- Industry
- Hospitals and Health Care
- Company size
- 51-200 employees
- Headquarters
- King of Prussia, Pennsylvania
- Type
- Privately Held
- Specialties
- Pharmacogenetics, Genetic Testing, Personalized Medicine, Consumer Genetics, Prescription genetic testing, Clinical Guidance, Telemedicine, Health and Wellness, Scientific Education, Prescription guidance, PhD and PharmD consults, Medication Management, Precision Medicine, Precision Health, Population Health, Precision Healthcare, Healthcare Solutions, Clinical Expertise, Treatment Optimization, and Risk Stratification
Locations
-
Primary
Get directions
2200 Renaissance Blvd
King of Prussia, Pennsylvania 19406, US
Employees at Genomind
-
Bill Brown
CEO at Genomind - Prescribe better, faster with Genomind
-
Philip Reich
Regional Manager South Florida - Genomind
-
Amy Pressman
Bring visibilities to healthcare brands through impactful B2B and B2C strategies.
-
Michael Wasielewski
Senior Regional Sales Director at Sanofi - Biosurgery Division
Updates
-
As we step into the New Year, Genomind is committed to overcoming healthcare’s biggest challenges. 🎉 On The 10 Minute HealthBizCast, our CEO, Bill Brown, talks about the power of pharmacogenetics and how we’re helping providers make smarter, faster decisions in 2024 and beyond. With new science and fresh possibilities, this year brings us one step closer to a future where personalized medicine is accessible to all. 🌟 Tune in to hear Bill’s vision for a healthcare system that works better for everyone. 🔗 Listen here: https://lnkd.in/eaUQGzKP #NewYearNewCare #Genomind #HealthcareInnovation #HealthBizCast #Pharmacogenetics #2024
Album 8, Track 7: The “Rapid, Incremental Change” Album
podcasts.apple.com
-
“68% of nursing home residents who were prescribed antipsychotics exhibited more behavioral issues after starting the medication compared to before.” An unspoken crisis for patients and their families, but genetic testing offers real hope. Along with alternate treatments, finding the right medication the first time - and deprescribing the wrong meds - is essential to helping this vulnerable population. Patients - and their families - deserve better. #PGx #pharmacogenetics #genetics
“We Need To Reconsider” – Scientists Expose Hidden Dangers of Antipsychotic Medications
https://scitechdaily.com
-
"Genetic testing holds particular promise in mental health, with estimates that one in 10 will experience mental illness at some point in their lives - a major driver of annual healthcare costs." "More than 50% of patients do not respond to their first psychiatric medication, and approximately 27% have adverse effects."
The Future of Prescriptions: Pharmacogenomic Testing on the Verge of Revolutionizing Health Care
https://goodmenproject.com
-
On The 10 Minute HealthBizCast, our CEO, Bill Brown, shared Genomind’s vision for empowering healthcare providers with insights into each patient’s unique genetics. Imagine the possibilities: targeted treatments, better outcomes, and lower healthcare costs. Hear Bill’s full vision for the future of medicine and how Genomind is bringing it to life. 🔗 Catch the episode here: https://lnkd.in/eaUQGzKP #QuoteOfTheDay #FutureOfHealthcare #Genomind #Pharmacogenetics #HealthBizCast
-
-
Our CEO, Bill Brown, just took center stage on the latest episode of The 10 Minute HealthBizCast with Bobby Guy! 🎙️ He dives into Genomind’s mission and groundbreaking pharmacogenetics testing, highlighting how we’re transforming healthcare through rapid, incremental change. 🌍 Don’t miss out on this powerful episode with insights into the biotech revolution. Catch the episode now and learn how Genomind is shaping the future of personalized medicine! 🔗 Listen now: https://lnkd.in/eaUQGzKP #HealthcareInnovation #Pharmacogenetics #BiotechRevolution #Genomind #HealthBizCast #PersonalizedMedicine
Deal attorney, author, and speaker specializing in changing healthcare and building successful healthcare companies
🚀 New Episode Alert: 10 Minute Health BizCast 🚀 Tune in to Track 7 of the 10 Minute Health BizCast where we dive into the biotech revolution that's transforming healthcare. In this episode, we chat with Bill Brown, CEO of Genomind about their groundbreaking testing innovations that are making healthcare better and more personalized. Explore the opportunities in new diagnostics and the biotech advancements that are shaping the future of healthcare. Don’t miss out on this insightful conversation and the chance to learn from a leader at the forefront of the biotech revolution. Catch the latest episode now and join the conversation about how biotech is changing the game for healthcare. 🎧 https://lnkd.in/e77cCENJ #biotech #biotechrevolution #diagnosticsrevolution #healthcareleadership #healthbizcast #changinghealthcare
-
-
We’re thrilled to announce our partnership with Evexia Diagnostics! 🎉 Together, we’re expanding access to our pharmacogenetic testing, giving more healthcare providers the tools to deliver personalized care. This collaboration marks an exciting new chapter in precision medicine! 🔬✨ https://lnkd.in/eTfrXyFc #PrecisionMedicine #Pharmacogenetics #Partnership #HealthcareInnovation
Evexia Diagnostics Partners with Genomind to Offer Genetic Tests
https://genomind.com
-
We’ve had an amazing time at #PsychCongress2024! Today is the last day to catch us in the exhibit hall—stop by booth 734 from 12:00 PM - 3:30 PM to see how Genomind is helping providers make better prescribing decisions with genetic insights. Thank you to everyone who’s visited us so far, and if you’re here, we’d love to connect before the exhibit hall closes! 🌟 #psychcongress2024 #psychcongress #psychopharmacology #mentalhealth #pharmacogenetics #PGx #education #networking
-
-
Our roadshow continues... This time, Genomind is exhibiting at Psych Congress 2024 in Boston! If you're here, come visit booth 734 and see how Genomind helps providers make better prescribing decisions using a patient's genetics. #psychcongress2024 #psychcongressfamily #psychcongress #psychiatry #psychcme #cmecredits #psychopharmacology #education #networking #psychmd #psychnp #psychpa #mentalhealth #mentalhealthcare #mentalhealtheducation #genetics #pharmacogenetics #PGx
-
-
Genomind helps providers make better prescribing decisions based on a patient's genetics. But because of the complexity of the results, patients are of often unable to understand the data in a meaningful way. With the Genomind Patient Report, patients now have a simple, readable report that clearly shows the key insights and how to take action, ensuring they can better align with their provider on a shared treatment plan. Congrats to the Genomind team on the amazing product release!
Genomind Launches First-of-Its-Kind Patient Report: Offering Patients an Easy-to-Understand View into Personalized Genetic Test Results
businesswire.com